118 related articles for article (PubMed ID: 29105997)
1. Doxorubicin induces ZAKα overexpression with a subsequent enhancement of apoptosis and attenuation of survivability in human osteosarcoma cells.
Fu CY; Tseng YS; Chen MC; Hsu HH; Yang JJ; Tu CC; Lin YM; Viswanadha VP; Kuo WW; Huang CY
Environ Toxicol; 2018 Feb; 33(2):191-197. PubMed ID: 29105997
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of ZAKβ in human osteosarcoma cells enhances ZAKα expression, resulting in a synergistic apoptotic effect.
Fu CY; Tseng YS; Chen MC; Hsu HH; Yang JJ; Tu CC; Lin YM; Viswanadha VP; Ding K; Kuo WW; Huang CY
Cell Biochem Funct; 2018 Jun; 36(4):176-182. PubMed ID: 29654619
[TBL] [Abstract][Full Text] [Related]
3. Fisetin activates Hippo pathway and JNK/ERK/AP-1 signaling to inhibit proliferation and induce apoptosis of human osteosarcoma cells via ZAK overexpression.
Fu CY; Chen MC; Tseng YS; Chen MC; Zhou Z; Yang JJ; Lin YM; Viswanadha VP; Wang G; Huang CY
Environ Toxicol; 2019 Aug; 34(8):902-911. PubMed ID: 31044527
[TBL] [Abstract][Full Text] [Related]
4. Selective Activation of ZAK β Expression by 3-Hydroxy-2-Phenylchromone Inhibits Human Osteosarcoma Cells and Triggers Apoptosis via JNK Activation.
Fu CY; Lay IS; Shibu MA; Tseng YS; Kuo WW; Yang JJ; Wang TF; Bharath BM; Yeh YL; Huang CY
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397561
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-184 Modulates Doxorubicin Resistance in Osteosarcoma Cells by Targeting BCL2L1.
Lin BC; Huang D; Yu CQ; Mou Y; Liu YH; Zhang DW; Shi FJ
Med Sci Monit; 2016 May; 22():1761-5. PubMed ID: 27222034
[TBL] [Abstract][Full Text] [Related]
6. P65-mediated miR-590 inhibition modulates the chemoresistance of osteosarcoma to doxorubicin through targeting wild-type p53-induced phosphatase 1.
Long X; Lin XJ
J Cell Biochem; 2019 Apr; 120(4):5652-5665. PubMed ID: 30387173
[TBL] [Abstract][Full Text] [Related]
7. A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro.
Rathore K; Cekanova M
Drug Des Devel Ther; 2015; 9():5323-35. PubMed ID: 26451087
[TBL] [Abstract][Full Text] [Related]
8. Combining GRP78 suppression and MK2206-induced Akt inhibition decreases doxorubicin-induced P-glycoprotein expression and mitigates chemoresistance in human osteosarcoma.
Xia YZ; Yang L; Xue GM; Zhang C; Guo C; Yang YW; Li SS; Zhang LY; Guo QL; Kong LY
Oncotarget; 2016 Aug; 7(35):56371-56382. PubMed ID: 27486760
[TBL] [Abstract][Full Text] [Related]
9. Autophagy prevents doxorubicin‑induced apoptosis in osteosarcoma.
Zhao D; Yuan H; Yi F; Meng C; Zhu Q
Mol Med Rep; 2014 May; 9(5):1975-81. PubMed ID: 24639013
[TBL] [Abstract][Full Text] [Related]
10. Andrographolide Induces Autophagic Cell Death and Inhibits Invasion and Metastasis of Human Osteosarcoma Cells in An Autophagy-Dependent Manner.
Liu Y; Zhang Y; Zou J; Yan L; Yu X; Lu P; Wu X; Li Q; Gu R; Zhu D
Cell Physiol Biochem; 2017; 44(4):1396-1410. PubMed ID: 29197865
[TBL] [Abstract][Full Text] [Related]
11. [Inhibition of Combination of Icaritin and Doxorubicin on Human Osteosarcoma MG-63 Cells in vitro].
Lin SW; Li XQ; Liu SY; Shi JM; Xu JH; Mao LH; Yin M
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jun; 36(6):729-34. PubMed ID: 27491234
[TBL] [Abstract][Full Text] [Related]
12. High expression of ABCG2 is associated with chemotherapy resistance of osteosarcoma.
Shu H; Yuan B; Huang Y; Wang L; He B; Sun Q; Sun L
J Orthop Surg Res; 2021 Jan; 16(1):85. PubMed ID: 33509236
[TBL] [Abstract][Full Text] [Related]
13. SM‑164 enhances the antitumor activity of adriamycin in human U2‑OS cells via downregulation of X‑linked inhibitor of apoptosis protein.
Chen J; Chen X; Chen X; Sun H; Yang D
Mol Med Rep; 2019 Jun; 19(6):5079-5086. PubMed ID: 31059038
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma.
Buondonno I; Gazzano E; Jean SR; Audrito V; Kopecka J; Fanelli M; Salaroglio IC; Costamagna C; Roato I; Mungo E; Hattinger CM; Deaglio S; Kelley SO; Serra M; Riganti C
Mol Cancer Ther; 2016 Nov; 15(11):2640-2652. PubMed ID: 27466354
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA CTA sensitizes osteosarcoma cells to doxorubicin through inhibition of autophagy.
Wang Z; Liu Z; Wu S
Oncotarget; 2017 May; 8(19):31465-31477. PubMed ID: 28415557
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells.
Castro-Gamero AM; Borges KS; da Silva Silveira V; Lira RC; de Paula Gomes Queiroz R; Valera FC; Scrideli CA; Umezawa K; Tone LG
Anticancer Drugs; 2012 Jul; 23(6):638-50. PubMed ID: 22382389
[TBL] [Abstract][Full Text] [Related]
17. Antitumorigenic Effects of ZAKβ, an Alternative Splicing Isoform of ZAK.
Lee JS; Lin YY; Wang TS; Liu JY; Lin WW; Yang JJ
Chin J Physiol; 2018 Feb; 61(1):25-34. PubMed ID: 29374956
[TBL] [Abstract][Full Text] [Related]
18. Serine/Threonine Kinase 35, a Target Gene of STAT3, Regulates the Proliferation and Apoptosis of Osteosarcoma Cells.
Wu Z; Liu J; Hu S; Zhu Y; Li S
Cell Physiol Biochem; 2018; 45(2):808-818. PubMed ID: 29414823
[TBL] [Abstract][Full Text] [Related]
19. Effect of CXCR4 on Apoptosis in Osteosarcoma Cells via the PI3K/Akt/NF-κβ Signaling Pathway.
Jiang C; Ma S; Hu R; Wang X; Li M; Tian F; Jiang W; Zhu L; Bian Z
Cell Physiol Biochem; 2018; 46(6):2250-2260. PubMed ID: 29734183
[TBL] [Abstract][Full Text] [Related]
20. Cardiomyocyte apoptosis vs autophagy with prolonged doxorubicin treatment: comparison with osteosarcoma cells.
Tacar O; Indumathy S; Tan ML; Baindur-Hudson S; Friedhuber AM; Dass CR
J Pharm Pharmacol; 2015 Feb; 67(2):231-43. PubMed ID: 25208656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
